Residential Construction
Compare Stocks
2 / 10Stock Comparison
TMHC vs LEN
Revenue, margins, valuation, and 5-year total return — side by side.
Residential Construction
TMHC vs LEN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Residential Construction | Residential Construction |
| Market Cap | $5.64B | $19.54B |
| Revenue (TTM) | $7.61B | $34.13B |
| Net Income (TTM) | $672M | $2.08B |
| Gross Margin | 22.4% | 17.6% |
| Operating Margin | 13.2% | 7.7% |
| Forward P/E | 11.4x | 14.7x |
| Total Debt | $2.36B | $6.32B |
| Cash & Equiv. | $851M | $3.80B |
TMHC vs LEN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Taylor Morrison Hom… (TMHC) | 100 | 312.2 | +212.2% |
| Lennar Corporation (LEN) | 100 | 149.8 | +49.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TMHC vs LEN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TMHC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.92
- Rev growth -0.6%, EPS growth -6.0%, 3Y rev CAGR -0.4%
- 338.9% 10Y total return vs LEN's 129.2%
LEN is the clearest fit if your priority is dividends.
- 2.2% yield; 12-year raise streak; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.6% revenue growth vs LEN's -3.6% | |
| Value | Lower P/E (11.4x vs 14.7x), PEG 0.35 vs 44.65 | |
| Quality / Margins | 8.8% margin vs LEN's 6.1% | |
| Stability / Safety | Beta 0.92 vs LEN's 0.92 | |
| Dividends | 2.2% yield; 12-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +4.6% vs LEN's -12.9% | |
| Efficiency (ROA) | 6.9% ROA vs LEN's 6.0%, ROIC 11.0% vs 7.9% |
TMHC vs LEN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TMHC vs LEN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
TMHC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LEN is the larger business by revenue, generating $34.1B annually — 4.5x TMHC's $7.6B. Profitability is closely matched — net margins range from 8.8% (TMHC) to 6.1% (LEN). On growth, LEN holds the edge at -6.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $7.6B | $34.1B |
| EBITDAEarnings before interest/tax | $1.0B | $2.8B |
| Net IncomeAfter-tax profit | $672M | $2.1B |
| Free Cash FlowCash after capex | $710M | $28M |
| Gross MarginGross profit ÷ Revenue | +22.4% | +17.6% |
| Operating MarginEBIT ÷ Revenue | +13.2% | +7.7% |
| Net MarginNet income ÷ Revenue | +8.8% | +6.1% |
| FCF MarginFCF ÷ Revenue | +9.3% | +0.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -26.8% | -6.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -51.2% | -52.5% |
Valuation Metrics
TMHC leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 7.8x trailing earnings, TMHC trades at a 32% valuation discount to LEN's 11.3x P/E. Adjusting for growth (PEG ratio), TMHC offers better value at 0.24x vs LEN's 44.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $5.6B | $19.5B |
| Enterprise ValueMkt cap + debt − cash | $7.1B | $22.0B |
| Trailing P/EPrice ÷ TTM EPS | 7.77x | 11.35x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.39x | 14.69x |
| PEG RatioP/E ÷ EPS growth rate | 0.24x | 44.65x |
| EV / EBITDAEnterprise value multiple | 6.26x | 7.64x |
| Price / SalesMarket cap ÷ Revenue | 0.69x | 0.57x |
| Price / BookPrice ÷ Book value/share | 0.96x | 1.05x |
| Price / FCFMarket cap ÷ FCF | 6.98x | 693.18x |
Profitability & Efficiency
TMHC leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
TMHC delivers a 10.8% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $9 for LEN. LEN carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to TMHC's 0.37x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +10.8% | +9.2% |
| ROA (TTM)Return on assets | +6.9% | +6.0% |
| ROICReturn on invested capital | +11.0% | +7.9% |
| ROCEReturn on capital employed | +13.2% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.37x | 0.29x |
| Net DebtTotal debt minus cash | $1.5B | $2.5B |
| Cash & Equiv.Liquid assets | $851M | $3.8B |
| Total DebtShort + long-term debt | $2.4B | $6.3B |
| Interest CoverageEBIT ÷ Interest expense | 19.94x | 198.24x |
Total Returns (Dividends Reinvested)
TMHC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TMHC five years ago would be worth $19,443 today (with dividends reinvested), compared to $9,353 for LEN. Over the past 12 months, TMHC leads with a +4.6% total return vs LEN's -12.9%. The 3-year compound annual growth rate (CAGR) favors TMHC at 11.7% vs LEN's -5.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +2.6% | -12.2% |
| 1-Year ReturnPast 12 months | +4.6% | -12.9% |
| 3-Year ReturnCumulative with dividends | +39.4% | -16.1% |
| 5-Year ReturnCumulative with dividends | +94.4% | -6.5% |
| 10-Year ReturnCumulative with dividends | +338.9% | +129.2% |
| CAGR (3Y)Annualised 3-year return | +11.7% | -5.7% |
Risk & Volatility
TMHC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
TMHC is the less volatile stock with a 0.92 beta — it tends to amplify market swings less than LEN's 0.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TMHC currently trades 83.2% from its 52-week high vs LEN's 62.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.92x | 0.92x |
| 52-Week HighHighest price in past year | $72.50 | $144.24 |
| 52-Week LowLowest price in past year | $54.58 | $83.03 |
| % of 52W HighCurrent price vs 52-week peak | +83.2% | +62.8% |
| RSI (14)Momentum oscillator 0–100 | 45.6 | 38.2 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 2.9M |
Analyst Outlook
LEN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates TMHC as "Buy" and LEN as "Buy". Consensus price targets imply 22.2% upside for TMHC (target: $74) vs 12.8% for LEN (target: $102). LEN is the only dividend payer here at 2.23% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $73.75 | $102.14 |
| # AnalystsCovering analysts | 30 | 50 |
| Dividend YieldAnnual dividend ÷ price | — | +2.2% |
| Dividend StreakConsecutive years of raises | 1 | 12 |
| Dividend / ShareAnnual DPS | — | $2.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.8% | +9.3% |
TMHC leads in 5 of 6 categories (Income & Cash Flow, Valuation Metrics). LEN leads in 1 (Analyst Outlook).
TMHC vs LEN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is TMHC or LEN a better buy right now?
For growth investors, Taylor Morrison Home Corporation (TMHC) is the stronger pick with -0.
6% revenue growth year-over-year, versus -3. 6% for Lennar Corporation (LEN). Taylor Morrison Home Corporation (TMHC) offers the better valuation at 7. 8x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Taylor Morrison Home Corporation (TMHC) a "Buy" — based on 30 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TMHC or LEN?
On trailing P/E, Taylor Morrison Home Corporation (TMHC) is the cheapest at 7.
8x versus Lennar Corporation at 11. 3x. On forward P/E, Taylor Morrison Home Corporation is actually cheaper at 11. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Taylor Morrison Home Corporation wins at 0. 35x versus Lennar Corporation's 44. 65x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — TMHC or LEN?
Over the past 5 years, Taylor Morrison Home Corporation (TMHC) delivered a total return of +94.
4%, compared to -6. 5% for Lennar Corporation (LEN). Over 10 years, the gap is even starker: TMHC returned +338. 9% versus LEN's +129. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TMHC or LEN?
By beta (market sensitivity over 5 years), Taylor Morrison Home Corporation (TMHC) is the lower-risk stock at 0.
92β versus Lennar Corporation's 0. 92β — meaning LEN is approximately 0% more volatile than TMHC relative to the S&P 500. On balance sheet safety, Lennar Corporation (LEN) carries a lower debt/equity ratio of 29% versus 37% for Taylor Morrison Home Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — TMHC or LEN?
By revenue growth (latest reported year), Taylor Morrison Home Corporation (TMHC) is pulling ahead at -0.
6% versus -3. 6% for Lennar Corporation (LEN). On earnings-per-share growth, the picture is similar: Taylor Morrison Home Corporation grew EPS -6. 0% year-over-year, compared to -44. 2% for Lennar Corporation. Over a 3-year CAGR, LEN leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TMHC or LEN?
Taylor Morrison Home Corporation (TMHC) is the more profitable company, earning 9.
6% net margin versus 6. 0% for Lennar Corporation — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TMHC leads at 14. 0% versus 8. 0% for LEN. At the gross margin level — before operating expenses — TMHC leads at 23. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TMHC or LEN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Taylor Morrison Home Corporation (TMHC) is the more undervalued stock at a PEG of 0. 35x versus Lennar Corporation's 44. 65x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Taylor Morrison Home Corporation (TMHC) trades at 11. 4x forward P/E versus 14. 7x for Lennar Corporation — 3. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TMHC: 22. 2% to $73. 75.
08Which pays a better dividend — TMHC or LEN?
In this comparison, LEN (2.
2% yield) pays a dividend. TMHC does not pay a meaningful dividend and should not be held primarily for income.
09Is TMHC or LEN better for a retirement portfolio?
For long-horizon retirement investors, Lennar Corporation (LEN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
92), 2. 2% yield, +129. 2% 10Y return). Both have compounded well over 10 years (LEN: +129. 2%, TMHC: +338. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TMHC and LEN?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
LEN pays a dividend while TMHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.